Abbott A L, Donnan G A
National Stroke Research Institute, Austin Health, Melbourne, Australia; Baker Heart Research Institute, Melbourne, Australia.
Eur J Vasc Endovasc Surg. 2008 May;35(5):524-33. doi: 10.1016/j.ejvs.2008.01.017. Epub 2008 Mar 5.
Recent evidence indicates that the risk of stroke symptoms in non-operated medically managed patients with asymptomatic severe carotid stenosis has fallen significantly over the last 25 years. This suggests concurrent improvements in vascular disease medical intervention efficacy. If the latest estimates of average annual stroke rate for non-operated patients are reflective of contemporary medical intervention and surgical stroke/death rates match those of the randomised trials, the current implication is that carotid surgery will not offer a stroke prevention advantage over medical intervention alone. Furthermore, it is still not possible to identify patients with asymptomatic severe carotid stenosis with a higher than average ipsilateral stroke risk despite current medical intervention. Even if such patients were one day reliably identified, they could also be at higher risk of stroke/death from instrumental intervention (surgery, angioplasty or stenting) and randomised trials will be required before being justification in routine clinical practice.
最近的证据表明,在过去25年中,非手术药物治疗的无症状重度颈动脉狭窄患者出现中风症状的风险已显著下降。这表明血管疾病医疗干预效果同时得到了改善。如果非手术患者的最新年均中风率估计反映了当代医疗干预情况,且手术中风/死亡率与随机试验的结果相符,那么目前的情况是,颈动脉手术相对于单纯药物干预并不能提供预防中风的优势。此外,尽管有当前的医疗干预,仍无法识别出同侧中风风险高于平均水平的无症状重度颈动脉狭窄患者。即使有一天能够可靠地识别出这类患者,他们也可能因器械干预(手术、血管成形术或支架置入术)而面临更高的中风/死亡风险,在将其应用于常规临床实践之前还需要进行随机试验。